Mobile

A single blind, placebo controlled, multi-centre study to investigate the pharmacokinetics, safety, tolerability and pharmacodynamics of the TRPV1 antagonist SB-705498 against the pain of acute migrai...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-004480-37

A single blind, placebo controlled, multi-centre study to investigate the pharmacokinetics, safety, tolerability and pharmacodynamics of the TRPV1 antagonist SB-705498 against the pain of acute migraine

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

•To assess the efficacy of SB-705498 in treating moderate-severe migraine headache

Critère d'inclusion

  • acute migraine

Liens